ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2026
[Identification of efferocytosis-related genes in osteoarthritis and prediction of traditional Chinese medicines based on bioinformatics and machine learning].
Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo screen key genes related to efferocytosis in osteoarthritis (OA) based on bioinformatics and machine learning methods, and explore their diagnostic value, immune microenvironment characteristics, and potential therapeutic targets of traditional Chinese medicines (TCM).
methodsOA-related datasets GSE55235, GSE55457, and GSE117999 were obtained from the GEO database. An efferocytosis-related gene set was retrieved from GeneCards. Differential expression analysis was performed to identify OA-related differentially expressed genes (DEGs) and their intersection with efferocytosis-related genes, followed by GO and KEGG enrichment analyses. Three machine learning algorithms (Random Forest, LASSO regression, and SVM) were used to screen feature genes, and their diagnostic efficacy was evaluated using ROC curves. qRT-PCR was used to validate the feature gene expressions in a rat OA model. Immune cell infiltration was analyzed using CIBERSORT, GSEA was used to explore the related pathways, and the Coremine database was utilized to predict TCMs associated with the feature genes.
resultsA total of 959 OA-related DEGs were identified, including 15 efferocytosis-related genes, which were enriched in leukocyte migration, extracellular matrix, and inflammatory pathways. Machine learning identified 3 feature genes, namely UCP2, EGLN3, and IL1B, which showed good diagnostic performance in both the training (GSE55235) and validation sets (GSE55457 and GSE117999) and varying expression patterns in the mouse models. Immune infiltration analysis showed significant differences in resting mast cells, resting memory CD4⁺ T cells, and activated mast cells between OA patients and healthy controls. The feature genes were closely associated with the adipocytokine signaling pathway, sulfur metabolism, and spliceosome pathway. A total of 100 TCMs were predicted, which were primarily herbs for tonifying deficiency, clearing heat, and promoting blood circulation, such as Lycium barbarum, Epimedium brevicornu, Rehmannia glutinosa, Sophora flavescens, Ligusticum chuanxiong, and Achyranthes bidentata.
conclusionsEfferocytosis-related genes play important roles in OA pathogenesis. UCP2, EGLN3, and IL1B have diagnostic value for OA. The predicted TCMs may serve as potential agents for OA prevention and treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.